use human embryonic stem cells model pediatric gliomas h33k27m histone mutation
% diffuse intrinsic pediatric gliomas aggressive brainstem tumor harbor heterozygous mutations create k27m amino acid substitution methionine replaces lysine tail histone h3 role h33k27m mutation tumorigenesis fully understood use human embryonic stem cell system model tumor show h33k27m expression synergizes p53 loss pdgfra activation neural progenitor cells derived human embryonic stem cells resulting neoplastic transformation genome-wide analyses indicate resetting transformed precursors developmentally primitive stem cell state evidence major modifications histone marks several master regulator genes drug screening assays identified compound targeting protein menin inhibitor tumor cell growth vitro mice
